Concepedia

Publication | Open Access

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

DOIFull Paper Access

127

Citations

20

References

2019

Year

Owen A. O’Connor, Lorenzo Falchi, Jennifer Kimberly Lue, Enrica Marchi, Cristina Kinahan, Ahmed Sawas, Changchun Deng, Francesca Montanari, Jennifer E. Amengual, Hye A. Kim,
Blood

Abstract

The authors report a phase 1 study of romidepsin combined with oral 5-azacytidine in patients with relapsed/refractory lymphomas, including complete remissions in 3 patients with angioimmunoblastic T-cell lymphoma.

References

YearCitations

Page 1